Back

ISG15-USP18 signaling restrains viperin-dependent metabolic antiviral restriction

Kahler, N. L.; Rezene, S.; Scholte, F. E.; Ambikan, A. T.; Saccon, E.; Monteil, V.; Naval, P.; Macmillan, R.; Frick, S.; Noren, J.; Lourda, M.; Mirazimi, A.; Bryceson, Y. T.; Lira-Junior, R.; Prasad, V.; Vegvari, A.; Neogi, U.; Bamford, C.; Hofer, A.; Bergeron, E.; Purhonen, J.; Gupta, S.

2026-03-14 microbiology
10.64898/2026.03.13.711570 bioRxiv
Show abstract

Type I interferon (IFN-I) responses are tightly regulated to balance antiviral defense with cellular homeostasis. In humans, interferon-stimulated gene 15 (ISG15) functions as a critical negative regulator of IFN-I signaling by stabilizing the IFN negative regulator USP18, yet the functional consequences of ISG15 deficiency remain elusive. Here, we show that the loss of ISG15 exaggerates the JAK-STAT activation and, downstream, amplifies multiple ISGs including the nucleotide-modifying enzyme RSAD2 (viperin). Our quantitative proteomics, genetic reconstitution, and signaling analyses establish that defective USP18 stabilization skews the IFN response towards viperin expression. This amplified ISG network promotes viperin-catalyzed accumulation of the antiviral nucleotide analog ddhCTP, resulting in enhanced inhibition of viral RNA synthesis and the replication of Crimean-Congo hemorrhagic fever virus and SARS-CoV-2. Together, these findings demonstrate an ISG15-USP18-viperin axis that can be targeted to boost the metabolic antiviral restriction.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.